EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Steroid Refractory Acute GVHD : The Hope for a Better Tomorrow

Portia Smallbone iD, Rohtesh S Mehta iD, Amin Alousi

American Journal of Hematology · 2025

DOI: 10.1002/ajh.27592 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Portia Smallbone und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Steroids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 118 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Steroid‐refractory acute graft‐versus‐host disease (SR‐AGVHD) presents a significant barrier to successful outcomes following allogeneic hematopoietic cell transplantation (HCT), despite advancements in GVHD prophylaxis and management. While ruxolitinib therapy has shown improved response rates, survival benefits remain elusive. This review explores the definitions and proposed distinct pathophysiology and treatment landscape of SR‐AGVHD. Emerging therapies offer potential, yet further research is critical to better define steroid‐refractory populations, improve treatment precision with biomarkers, and overcome resistance, particularly in ruxolitinib‐refractory cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationSteroidsHumansAcute DiseaseNitrilesPyrazolesPyrimidinesDrug ResistanceTransplantation, HomologousAllografts

Stichwörter der Autor:innen

graft‐versus‐host diseasehematopoietic stem cell transplantationimmunomodulatory therapiessteroid‐refractory

Substanzen

NitrilesPyrazolesruxolitinibPyrimidinesSteroids

Autor:innen und Institutionen

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Portia Smallbone, Rohtesh S Mehta

Zitieren

APA

Smallbone, P., Mehta, R. S., & Alousi, A. (2025). Steroid Refractory Acute GVHD : The Hope for a Better Tomorrow. American Journal of Hematology. https://doi.org/10.1002/ajh.27592

Vancouver

Smallbone P, Mehta RS, Alousi A. Steroid Refractory Acute GVHD : The Hope for a Better Tomorrow. American Journal of Hematology. 2025. doi:10.1002/ajh.27592

BibTeX
@article{Smallbone2025,
  author = {Smallbone, Portia and Mehta, Rohtesh S and Alousi, Amin},
  title = {Steroid Refractory Acute GVHD : The Hope for a Better Tomorrow},
  journal = {American Journal of Hematology},
  year = {2025},
  doi = {10.1002/ajh.27592}
}
Kostenlos starten →